MALAT1 was first shown to be over-expressed in hepatoblastomas compared to hepatocellular carcinomas [16], and later investigations have indicated that MALAT1 is also upregulated in colon, breast, prostate and non-small cell lung cancer (NSCLC) [17–20]. Here, MALAT1 is linked to hepatocellular carcinoma.